CBL (Chemical and Biopharmaceutical Laboratories) Patras, established in 1990, stands as a prominent global figure in peptide production technology. Recognized as a major provider of peptide resources on a worldwide scale, CBL delivers initial components, middle stages, and large-scale synthesis of both GMP and non-GMP peptides. Covering over 10,000 square meters, CBL encompasses four buildings dedicated to laboratories and manufacturing. Operating with highly automated and efficient facilities, CBL conducts solid and solution-phase syntheses at various levels. The cutting-edge equipment and proficient knowledge at CBL have played a crucial role in the creation of intricate peptides for diverse purposes.
Products & Services
Custom Peptide Synthesis & Manufacturing
GMP Manufacturing of Peptides
Human Epidermal Growth Factor
Liraglutide
Sites
Country
GreeceCountry
GreeceCity
Patra
Address
Achaias, 265 04